about
Fast-forwarding hit to lead: aurora and epidermal growth factor receptor kinase inhibitor lead identificationThe combination effects of licl and the active leflunomide metabolite, A771726, on viral-induced interleukin 6 production and EV-A71 replicationIdentification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus.Targeting Tumor Associated Phosphatidylserine with New Zinc Dipicolylamine-Based Drug Conjugates.Anti-influenza drug discovery: identification of an orally bioavailable quinoline derivative through activity- and property-guided lead optimization.Design and synthesis of tetrahydropyridothieno[2,3-d]pyrimidine scaffold based epidermal growth factor receptor (EGFR) kinase inhibitors: the role of side chain chirality and Michael acceptor group for maximal potency.Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains.
P50
Q27662315-E8B4B085-E4F5-4CC1-AFAD-287C94AF640AQ28545087-063133C2-2168-4054-A136-5A9844B255E3Q34022729-964DC4E1-190F-400B-8B52-ED515EACE2E9Q38701249-E46E612C-42EF-4BD6-8D44-FF2F6B135CA5Q39310148-3E4978B9-7837-46FE-8AF8-9D2D335796E3Q39641906-82BF31FC-F76B-4D1C-BE15-68DA35FAF217Q41929666-758818CB-4546-49FB-BB05-30C1A77FCA73
P50
description
investigador
@es
researcher
@en
name
Ming-Yu Fang
@en
type
label
Ming-Yu Fang
@en
prefLabel
Ming-Yu Fang
@en
P31
P496
0000-0002-2530-7522